Cargando…
Glucose Metabolism is a Better Marker for Predicting Clinical Alzheimer’s Disease than Amyloid or Tau
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8975178/ https://www.ncbi.nlm.nih.gov/pubmed/35373192 |
| _version_ | 1784680346947682304 |
|---|---|
| author | Hammond, Tyler C. Lin, Ai-Ling |
| author_facet | Hammond, Tyler C. Lin, Ai-Ling |
| author_sort | Hammond, Tyler C. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8975178 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-89751782022-04-01 Glucose Metabolism is a Better Marker for Predicting Clinical Alzheimer’s Disease than Amyloid or Tau Hammond, Tyler C. Lin, Ai-Ling J Cell Immunol Article 2022 /pmc/articles/PMC8975178/ /pubmed/35373192 Text en https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
| spellingShingle | Article Hammond, Tyler C. Lin, Ai-Ling Glucose Metabolism is a Better Marker for Predicting Clinical Alzheimer’s Disease than Amyloid or Tau |
| title | Glucose Metabolism is a Better Marker for Predicting Clinical Alzheimer’s Disease than Amyloid or Tau |
| title_full | Glucose Metabolism is a Better Marker for Predicting Clinical Alzheimer’s Disease than Amyloid or Tau |
| title_fullStr | Glucose Metabolism is a Better Marker for Predicting Clinical Alzheimer’s Disease than Amyloid or Tau |
| title_full_unstemmed | Glucose Metabolism is a Better Marker for Predicting Clinical Alzheimer’s Disease than Amyloid or Tau |
| title_short | Glucose Metabolism is a Better Marker for Predicting Clinical Alzheimer’s Disease than Amyloid or Tau |
| title_sort | glucose metabolism is a better marker for predicting clinical alzheimer’s disease than amyloid or tau |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8975178/ https://www.ncbi.nlm.nih.gov/pubmed/35373192 |
| work_keys_str_mv | AT hammondtylerc glucosemetabolismisabettermarkerforpredictingclinicalalzheimersdiseasethanamyloidortau AT linailing glucosemetabolismisabettermarkerforpredictingclinicalalzheimersdiseasethanamyloidortau |